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During an infection the antigen-nonspecific memory
CD8 T cell compartment is not simply an inert pool
of cells, but becomes activated and cytotoxic. It is
unknown how these cells contribute to the clearance
of an infection. We measured the strength of T cell
receptor (TCR) signals that bystander-activated,
cytotoxic CD8 T cells (BA-CTLs) receive in vivo
and found evidence of limited TCR signaling. Given
this marginal contribution of the TCR, we asked
how BA-CTLs identify infected target cells. We
show that target cells express NKG2D ligands
following bacterial infection and demonstrate that
BA-CTLs directly eliminate these target cells in an
innate-like, NKG2D-dependent manner. Selective
inhibition of BA-CTL-mediated killing led to a signifi-
cant defect in pathogen clearance. Together, these
data suggest an innate role for memory CD8
T cells in the early immune response before the
onset of a de novo generated, antigen-specific
CD8 T cell response.
INTRODUCTION
Antigen-nonspecific memory CD8 T cells are activated in an
inflammation-dependent bystander fashion during the course
of an infection (Berg et al., 2003; Doisne et al., 2004; Kohlmeier
et al., 2010; Marshall et al., 2010; Odumade et al., 2012; Soudja
et al., 2012; Su et al., 2005; Tough et al., 1996). This holds true in
clinical studies as well as in mouse model systems: cytomegalo-
virus (CMV)-, Epstein-Barr virus (EBV)-, and influenza-specific
CD8 memory T cells are bystander activated during a primary
HIV infection (Doisne et al., 2004), and influenza- and CMV-
specific cells are bystander activated during primary EBV infec-
tion (Odumade et al., 2012). Data from animal studies show that
CD8 memory cells can be bystander activated to produce inter-
feron g (IFNg) in the absence of cognate antigen, which can bebeneficial for the host (Berg et al., 2003; Kastenmu¨ller et al.,
2012; Kohlmeier et al., 2010; Kurepa et al., 2003; Marshall
et al., 2010; Su et al., 2005). More recently, it was shown that
both monocytes and dendritic cells contribute to inducing this
bystander activation of CD8 T cells, leading to IFNg and gran-
zyme B production (Soudja et al., 2012).
Although it has been demonstrated that bystander activation
occurs in a number of infections, the biological relevance of
bystander-activated memory cells and their actual contribution
to resolving an infection are poorly defined. The observation
that bystander-activated memory cells can make granzyme B
was attributed to potential cross-reactivity between the cognate
antigen recognized by the memory T cell and new pathogen
epitopes (Marshall et al., 2010), and killing was restricted to
target cells presenting cognate antigen (Kohlmeier et al., 2010).
These data raise the possibility that acquisition of cytotoxic
potential would only be beneficial in some but not all new infec-
tions, depending on the extent of antigen cross-reactivity. T cell
cross-reactivity against pathogens has been suggested to be
fairly extensive even if the pathogens are unrelated (Welsh
et al., 2010). This raises the possibility that strong, agonist-like
T cell receptor (TCR) signals play an essential role in the absence
of cognate antigen and are involved in the process of bystander
activation. In addition to infection, bystander activation of CD8
memory T cells has also been observed in instances of autoim-
munity. In the case of celiac disease, these CD8 T cells differen-
tiate in response to pathologically high levels of interleukin-15
(IL-15) and acquire a natural killer (NK) cell phenotype, including
expression of NK-cell-specific markers (Meresse et al., 2004). It
is unknown whether these cells are autoreactive effector cells or
are truly bystander activated, but it has been demonstrated that
these differentiated cells can attack target cells in an NKG2D-
dependent manner. Regardless of the immunological context
of bystander activation, the role of TCR signals for bystander
activation and function has not been fully addressed. Thus, it is
unclear whether there is at least a partial role for a TCR stimulus,
which would point to an integral role for the TCR in controlling
T cell function at all times. The likelihood of antigen cross-reac-
tivity needs to be especially considered in light of the frequent
expression of more than one TCRa chain that can pair with theCell Reports 3, 701–708, March 28, 2013 ª2013 The Authors 701
TCRb chain in polyclonal and TCR-transgenic T cell pools (Heath
et al., 1995).
We decided to use Nur77-GFP reporter mice (Moran et al.,
2011) tomeasure the role of TCRsignals during bystander activa-
tion. These mice express GFP from the Nur77 locus, and induc-
tion of GFP expression is strictly dependent on a TCR stimulus
and cannot be induced by cytokines.We found that CD8memory
cells could acquire bystander-activated, cytotoxic CD8 T cell
(BA-CTL) function without the involvement of a strong, agonist
TCR signal. Brief exposure to IL-12, IL-15, and IL-18 acting
directly on the T cells was sufficient to induce cytotoxic potential.
Given thisminimal role of the TCR,we hypothesized thatmemory
CD8 T cells could have a TCR-independentmeans of recognizing
and killing infected target cells.We found that during an infection,
memory CD8 T cells temporarily acquire an innate-like killing
potential and kill target cells in an NKG2D-dependent manner.
Most importantly, BA-CTL function was necessary to mediate
early pathogen clearance during Listeria monocytogenes (LM)
infection. Thus, BA-CTLs are an essential component of the
immune response against a pathogen. We propose that the early
response of BA-CTLs serves to control pathogen replication until
the primary immune response springs into action. Our experi-
ments provide insight into the possible therapeutic potential of
these cells, as well as the risk of causing pathologies.
RESULTS AND DISCUSSION
Acquisition of Innate-like Effector Function in the
Absence of Strong TCR Signals
We first used an experimental system with defined TCR speci-
ficity to define BA-CTL phenotype and function. We generated
memory T cells by transferring low numbers of congenically
marked, naive OT-I T cells into B6 mice. OT-I cells recognize
the SIINFEKL (N4) epitope of chicken ovalbumin (OVA) (Hogquist
et al., 1994). Mice were infected with a recombinant strain
of vesicular stomatitis virus (VSV-OVA) to prime OT-I T cells.
Thirty days after the VSV-OVA infection, we infected the mice
with wild-type LM (WT-LM), which does not express any
antigen with agonist properties for OT-I T cells (i.e., does not
prime naive OT-I T cells) to induce bystander activation. In an
effort to identify a possible TCR-independent killing mechanism
used by bystander-activated cytotoxic CD8 memory cells (BA-
CTLs), we phenotyped BA-CTLs for expression of receptors
associated with NK cell activation. NK cells have been shown
to have similarities with CD8 memory T cells with regard to
phenotype, function, and gene expression patterns (Bezman
et al., 2012; Sun and Lanier, 2011), and expression of inhibitory
and activating NK cell receptors on activated and memory
CD8 T cells has been reported (Coles et al., 2000; McMahon
et al., 2002; Slifka et al., 2000).
The majority of the resting memory OT-I T cells expressed
NKG2D, but not granzyme B, before the WT-LM challenge
(day 0; Figure 1A [this time point is 30 days after the VSV-OVA
infection]). Approximately half of the OT-I memory cells ex-
pressed granzyme B on day 3 after the WT-LM infection, and
thus displayed a BA-CTL phenotype (Figure 1A), but this
percentage decreased on day 5 post WT-LM infection. One
potential explanation for this observation is that BA-CTL function702 Cell Reports 3, 701–708, March 28, 2013 ª2013 The Authorsis temporary and wanes by the time the primary effector
response becomes robust. There was no significant change in
the frequency of OT-I T cells (data not shown). The BA-CTLs
did not express the NK-specific receptor NKp46 at any given
time (Figure 1B; data not shown), which suggests that they did
not differentiate into NK-like cells as was previously observed
during pathologic exposure to high levels of IL-15 (Meresse
et al., 2004). To exclude the possibility that we were studying
a TCR transgenic artifact, we next sought to determine whether
BA-CTLs could be generated in a polyclonal memory-like
(CD44hi) CD8 population following infection with recombinant
LM expressing the model antigen ovalbumin (LM-OVA). Within
48 hr of infection, a significant fraction of memory-like CD44hi
CD8 T cells expressed granzyme B and NKG2D (Figure 1C).
The overall percentage of granzyme B+ cells remained fairly
constant in the first 3 days. Thus, similarly to memory OT-I
T cells, a polyclonal memory phenotype population responds
rapidly to a new infection. We next wanted to determine whether
these polyclonal memory T cells are truly activated in a cytokine-
dependent and TCR-independent manner.
We considered that generation of BA-CTLs could (1) be
completely independent of TCR signals, (2) need at least a basal
signal (TCR tickling), or (3) depend on stronger than basal
signals, possibly provided by cross-reactivity of the activated
T cell to available antigen at any point in the activation process.
BA-CTLs are not necessarily a homogeneous population and
can be composed of some cells that are purely inflammation
activated and others that have cross-reactivity and are activated
by TCR signals. To address these possibilities, we used the
recently described Nur77-GFP reporter mice. Moran et al.
(2011) reported that in Nur77-GFP transgenic mice, the GFP
expression level in T cells is directly proportional to the strength
of the TCR stimulus a T cell receives and, importantly, is inde-
pendent of inflammatory signals. This was specifically shown
in the context of an LM infection. Most importantly, the Nur77-
GFP system is sensitive enough to report even very weak TCR
signals. Nur77-GFP OT-I T cells that are primed with LM-V4
(SIIVFEKL), an antigen that is 700-fold less potent than
SIINFEKL (Zehn et al., 2009), still express high levels of GFP
(Moran et al., 2011).We thus believe that the Nur77-GFP reporter
mouse is ideal for addressing the role of TCR signals in BA-CTL
generation. To establish the baseline and maximum GFP signal,
we left one group of mice untreated and injected another group
with a-CD3 antibody (Ab) as a positive control for TCR signaling
(Figure 1D). We directly infected naive Nur77-GFPmice with LM-
OVA and determined GFP expression levels in the CD44hi
NKG2D+ granzyme B+ population 48 hr after the infection (Fig-
ure 1D). CD44hi NKG2D+ granzyme B+ CD8 T cells in the LM-
OVA-infected group displayed GFP expression levels above
the baseline of naive CD44lo CD8 T cells (Figure 1E, middle
panel) but congruent with the expression levels of the overall
CD44lo+hi CD8 control population (Figure 1E, left panel). BA-
CTLs with the brightest GFP signal did not reach the level of
GFP expression in the a-CD3-treated group (Figure 1E). It is
noteworthy that BA-CTLs and CD8 T cells from the a-CD3-
treated group were blasting and significantly larger in size than
the baseline control population (Figure 1E, right panel). Although
BA-CTLs do receive a TCR signal above the naive CD44lo
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Figure 1. The BA-CTL Phenotype Is
Acquired Early after Infection in the Pres-
ence of Weak TCR Signals
(A) OT-I T cells (1 3 104) were adoptively trans-
ferred into congenic C57BL/6 mice, followed by
infection with VSV-OVA. Thirty days later, the mice
were infected i.v. with 2,000 colony-forming units
(cfu) WT-LM. The mice were bled before (day 0)
and on day 3 and day 5 after WT-LM infection and
analyzed for phenotype and function.
(B) OT-I BA-CTLs did not express NKp46 at any
of these time points (histogram shows staining
from day 3).
(C) C57BL/6 mice were infected with 2,000 cfu
LM-OVA and euthanized for analysis on days 0, 2,
and 3 after infection. Data shown are gated on
CD8+ CD44+ T cells.
(D) Nur77-GFP mice were infected with 2,000 cfu
LM-OVA or injected with 50 mg aCD3 Ab, or left
untreated (control). Mice were euthanized for
analysis on day 2 after infection.
(E) GFP expression levels of BA-CTLs (CD44hi
NKG2D+ granzyme B+, black semitransparent
histogram) and CD8 T cells from aCD3-treated
animals (blue histogram) were compared with
theGFPexpression levelsofcontrol (CD44lo+hi)CD8
T cells (red histogram, left panel) and CD44lo naive
CD8 (red histogram, middle panel). The cell sizes
of control (CD44lo+hi) CD8 T cells, BA-CTLs, and
CD8 T cells from aCD3-treated animals (right
panel) were compared. Data shown are represen-
tative of at least three independent experiments.baseline, as indicated by the overall shift in GFP expression, our
data also show that BA-CTLs do not receive TCR stimuli above
the threshold of CD44hi CD8 T cells in an uninfected animal.
Together, these data suggest that BA-CTLs receive TCR signals
of limited strength during activation. We next wanted to deter-
mine which signals can directly control granzyme and NKG2D
expression.
Cytotoxic Function and Recognition of Target Cells
Previous studies have demonstrated a role for IL-15 in regulating
granzyme expression in CD8 T cells (Marshall et al., 2010; Mer-
esse et al., 2004; Soudja et al., 2012). It is currently unclear which
factors regulate NKG2D expression on memory cells, although
IL-4 has been shown to negatively regulate NKG2D expression
in memory CD8 T cells (Ventre et al., 2012). Murine CD8 T cells
start to express NKG2D during the effector stage, and 60%–
90% of VSV-OVA-primed OT-I memory cells express NKG2D
30 days postinfection (day 0; Figure 1A). OT-I cells that acquired
a memory phenotype by homeostatic expansion expressed
NKG2D as well, albeit at a reduced frequency (15%–35%; data
not shown).
We tested whether exposure to IL-12, IL-15, and IL-18 could
directly induce granzyme expression and affect NKG2D expres-Cell Reports 3, 701–70sion in naive andmemory phenotype OT-I
T cells. These cytokines were previously
shown to activate memory T cells
(Smeltz, 2007). We found granzyme ex-pression in the memory phenotype population (CD44high), but
not in the naive CD8 T cell population, after 6 hr of incubation
with IL-12, IL-15, and IL-18 (Figure 2A). Expression of granzyme
by memory phenotype CD8 T cells in such a short time frame
suggests that this occurs in the absence of cell proliferation.
The fraction of NKG2D expressing memory CD8 T cells in-
creased slightly over the course of 24 hr, but naive CD8 T cells
remained NKG2D and granzyme B negative. These data suggest
that IL-12, IL-15, and IL-18 can act directly on memory CD8
T cells and are sufficient to induce BA-CTL function, but are
not the primary regulators of NKG2D expression.
Monocytes express NKG2D ligands (the Rae-1 family, H60,
and Mult-1 in the mouse, and MICA, MICB, and the ULBP family
in humans; Zafirova et al., 2011) in response to TLR agonists
such as lipopolysaccharide and WT-LM in vitro (Hamerman
et al., 2004). We infected mice with 1 3 107 cfu of actA LM-
OVA and determined Rae-1 and Mult-1 expression 24 hr later
to identify possible BA-CTL target cells. The actA Listeria strain
was used to increase the number of initially infected cells. We
found substantial upregulation of both ligands on CD11c+
MHC class II+ cells in the spleen (Figure 2B), which are the
predominantly infected cells early after infection with Listeria
(Neuenhahn et al., 2006). To determine whether BA-CTLs can8, March 28, 2013 ª2013 The Authors 703
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Figure 2. Expression of NKG2D Ligands on Target Cells following Infection and Direct Killing by BA-CTLs
(A) Spleen OT-I T cells were enriched for naive or memory phenotype cells and cultured in vitro with IL-12, IL-15, and IL-18 (each cytokine at 2 ng/ml). NKG2D and
granzyme B expression was measured before culturing (0 hr) and after 6 hr and 24 hr of culturing.
(B) Mice were infected with 107 cfu ActA LM-OVA (used only in this set of experiments to increase the number of initially infected cells). Expression of Mult-1 and
Rae-1 was determined 24 hr postinfection on I-Ab+ CD11c+ cells. Levels of NKG2D ligand expression on I-Ab+ CD11c+ cells from infected mice and uninfected
control mice are shown in blue and red, respectively.
(C) RMA control cells were labeled with a low dose (0.2 mM) of CTV, and RMA-Rae1-expressing target cells were labeled with a higher dose of CTV (5 mM). The
cells were mixed at a 1:1 ratio and incubated with OT-I BA-CTLs for 5 hr in vitro at an E:T ratio of 6:1. The CTV low-to-high ratio of the remaining live cells was
determined by FACS analysis. Dead cells were excluded by propidium iodide staining. We included 1 mMSIINFEKL pulsed RMA cells as a positive control group
and an RMA+RMA group as a negative control group. FACS-purified OT-I BA-CTLs (generated as described in Figure 1A) were isolated on day 3 after LM
infection. Data shown are representative of at least three independent experiments and are plotted as mean with SD.directly lyse NKG2D-ligand-expressing target cells, we used the
VITAL in vitro killing assay (Hermans et al., 2004). We found that
OT-I BA-CTLs could kill RMA-Rae1-expressing cells (but not
RMA cells), albeit less efficiently than SIINFEKL pulsed RMA
cells (Figure 2C). These data suggest that BA-CTLs can directly
kill target cells in an NKG2D-dependentmanner.We consistently
observed higher killing efficiency when the TCR was engaged.
Whether this is due to differences in cytotoxic granule release
per se or in formation of synapses that direct the granules to
the target cells (Anikeeva and Sykulev, 2011) remains to be
determined. It is also important to keep in mind that these differ-
ences are observed in a system that is based on expression of
only one NKG2D ligand (Rae-1) on the target cells and a high
dose of strong agonist peptide in the positive control. Future
efforts will show how these killing mechanisms compare in vivo
in terms of efficiency.
Providing Early Protection—A Crucial Role for BA-CTLs
Our data so far suggest that expression of NKG2D ligands after
infection and the ability of BA-CTLs to directly recognize induced
NKG2D ligands constitute a potential mechanism to eliminate in-
fected cells. We next asked whether BA-CTL-mediated, innate-
like killing does indeed occur in vivo and, most importantly,704 Cell Reports 3, 701–708, March 28, 2013 ª2013 The Authorswhether it affects the course of an infection by blocking
NKG2D on BA-CTLs. We administered an NKG2D-blocking Ab
(HMG2D) (Ito et al., 2008) 2 days before and after infecting
mice with LM-OVA. Mice were also injected with depleting
aNK1.1 Ab (PK136) to eliminate potential skewing of the results
by NK and NKT cells, which can also express NKG2D. There was
no significant difference in bacterial counts on day 3 postinfec-
tion (Figure 3A), excluding an effect on very early, innate immu-
nity, but there was a >1 log increase in bacterial counts on day
5 after infection in aNKG2D-Ab-treated mice (Figure 3B). We
also excluded a potential effect of gd T cells in LM clearance in
follow-up experiments (data not shown).
BA-CTLs in the aNKG2D/PK136-Ab-treated group still ex-
pressed granzyme B (Figure 3C), indicating that NKG2D-medi-
ated signals are not required for BA-CTL/effector acquisition
(as also indicated in Figure 2A) but are critical for identifying
target cells and possibly for granule exocytosis in the absence
of a TCR signal. IFNg production by newly induced effectors
after SIINFEKL stimulation was small, as expected, on day 5,
but was equivalent in all three groups (the ‘‘no-Ab group’’ is
not shown) and above the no-restimulation background,
suggesting that treatment with the NKG2D-blocking Ab did
not affect the antigen-specific response (Figure 3C). Thus, we
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Figure 3. BA-CTLs Limit Early Pathogen Replication
Micewere left untreated, injected with an NK-depleting Ab (PK136) and an NKG2D-blocking Ab (HMG2D), or injected with PK136 alone 2 days before and after an
infection with 2,000 cfu LM-OVA. Data are pooled from three independent experiments.
(A and B) Bacterial load in the spleen was determined on (A) day 3 and (B) day 5, and is shown as the mean with SEM. The limit of detection (LOD) is indicated by
a black bar. Mice that did not show any detectable bacterial load are marked as being at the LOD.
(C) Granzyme B and IFNg expression by CD8 T cells was measured on day 5 in all experimental groups (the ‘‘no-Ab’’ group is not shown) following in vitro
stimulation with OVA peptide for 4 hr.propose that NKG2D-dependent, BA-CTL-mediated cytotox-
icity plays a crucial, albeit not necessarily exclusive, role in
controlling early bacterial replication.
To further ensure that the increase in bacterial load was not
due to an effect of the NKG2D-blocking Ab on the primary
CD8 T cell response, we determined the size, phenotype, and
function of the primary antigen-specific CD8 T cells in follow-
up experiments. We compared the responses of adoptively
transferred OT-I T cells in the presence and absence of
NKG2D-blocking Ab and found that aNKG2D Ab treatment did
not affect the size (Figure 4A) or function (Figure 4B) of the
effector OT-I T cell response on day 5 after infection with LM-
OVA. These data along with published reports (Rajasekaran
et al., 2010; Zafirova et al., 2011) strongly suggest that NKG2D
is dispensable for generating a primary CD8 T cell response.
Importantly, the aNKG2D-Ab-treated animals again had signifi-
cantly higher bacterial cfu than animals from the two control
groups (Figure 4C, middle panel). These data show that a 100-
fold increase in the precursor frequency (from100 endogenous
CD8 responders to 1 3 104 OT-I T cells) and the ensuing large
pool of effector cells did lower the bacterial burden in all
three groups compared with untransferred, infected B6 mice
(compare Figure 3B, right-hand panel, and Figure 4C), indicatingproper effector function and further supporting our conclusion
that the primary T cell response and effector function are not
affected by aNKG2D Ab treatment. Importantly, a significant
impact on bacterial clearance by BA-CTLs was still observed.
This further underlines the biological significance of the BA-
CTL population as an important contributor of early immunity,
as even artificially increasing the antigen-specific T cell pool at
an early time point by transferring OT-I T cells could not compen-
sate for BA-CTL-mediated bacterial clearance.
In summary, our data show that BA-CTLs play a crucial role in
limiting pathogen replication at the early stages of an infection,
pointing to an additional role of memory CD8 T cells. BA-CTLs
limit pathogen replication prior to the onset of the de novo,
antigen-specific CD8 T cell response, and thus precede TCR-
dependent target cell elimination. We provide evidence that
they do so by recognizing target cells in an NKG2D-dependent
manner. Why would BA-CTLs essentially mimic NK cells in their
ability to kill NKG2D-ligand-expressing target cells?We propose
that this functional redundancy may provide advantages to the
host, for the following reasons: (1) signals that can inhibit NK
cell function (e.g., viral proteins mimicking MHC class I) likely
do not affect BA-CTLs, because only a small fraction of BA-
CTLs express inhibitory Ly49 receptors (data not shown); andCell Reports 3, 701–708, March 28, 2013 ª2013 The Authors 705
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Figure 4. The Primary CD8 T Cell Response
Occurs Independently of NKG2D Signaling
and Cannot Compensate for the Loss of
BA-CTL Activity
Mice were injected with depleting and/or blocking
Ab and infected with LM-OVA as described in
Figure 3. Mice received 104 naive OT-I T cells on
the day of infection.
(A) The size of the OT-I T cell population on day 5 is
shown as a percentage of the total CD8 T cell pool.
(B) Percentage of granzyme B-expressing OT-I
T cells in the three experimental groups.
(C) Bacterial load in the spleen on day 5 post-
infection. Data shown are representative of two
independent experiments and plotted as themean
with SEM.(2) given the considerable size of the CD8memory compartment,
BA-CTLs can be a very large population that outnumbers NK
cells and hence is capable of effectively limiting viral or bacterial
spreading.
Although NKG2D ligand expression may not occur in all
infections, we think that the fact that TLR stimulation induces
NKG2D ligand expression in macrophages (Hamerman et al.,
2004) is a very good indicator that this is a broadly applicable
rather than specific mechanism. Safe activation of memory cells
to temporarily transform them into BA-CTLs could potentially
be used to help clear infections (e.g., after bone marrow trans-
plantation when antigen-specific cells are scarce) and NKG2D
ligand-expressing tumors. Our data suggest that both bona
fide TCR transgenic antigen-experienced memory T cells and
polyclonal memory phenotype cells can be bystander activated.
The ability of memory CD8 T cells to turn into BA-CTLs may be
situation dependent; for example, exhausted and senescent
memory T cells may differ in their ability to become BA-CTLs.
Understanding the potential of homeostatically expanded
memory phenotype T cells to become BA-CTLs in patients
who have undergone myeloablative treatment and are suscep-
tible to opportunistic infections will be of great interest.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6 and C57BL/6 Thy1.1+ mice were obtained from The Jackson Labo-
ratory (Bar Harbor, ME) and housed in specific pathogen-free conditions in
the animal facilities at the University of Washington (Seattle, WA) and the
Fred Hutchinson Cancer Research Center (Seattle, WA). OT-I TCR transgenic
mice congenic for CD45.1 or Thy1.1 were bred and maintained in the same
facilities. Nur77-GFP mice were housed at the La Jolla Institute for Allergy
and Immunology (La Jolla, CA).706 Cell Reports 3, 701–708, March 28, 2013 ª2013 The AuthorsInfections and BA-CTL Generation
LM, LM-OVA, and actA LM-OVA were grown
as previously described (Zehn et al., 2009). For
primary infections, C57BL/6 mice were injected
i.v. with 2 3 103 cfu WT-LM or LM-OVA. Bacterial
countsweremeasured by homogenizing a fraction
of the spleen in 0.1% IGEPAL and plating on BHI
plates. To determine NKG2D ligand expression,
mice were infected with 107 cfu actA LM-OVA
(i.v.). To generate BA-CTL OT-I T cells, mice
received 1 3 104 naive (CD44lo) OT-I T cells andsubsequently were infected (i.v.) with 2 3 106 plaque-forming units (pfu) of a
recombinant VSV strain expressing the SIINFEKL epitope (Kim et al., 1998).
Then >30 days after VSV-OVA infection, the mice were infected with
2,000 cfu WT-LM.
In Vitro BA-CTL Induction
Memory phenotype cells were isolated from OT-I spleens by depleting
CD62Lhi bead-labeled OT-I T cells along with other cell populations in a
magnetic column (Miltenyi). Naive OT-I T cells were isolated by depleting
CD44hi-expressing OT-I T cells in the same manner.
VITAL Assay
CD45.1+ OT-I BA-CTLs for the VITAL assay were first enriched from the
spleens of day 3 infected B6 mice for CD8 T cells by depleting bead-labeled
CD4, CD19, and I-Ab-expressing cells using a magnetic column (Miltenyi), fol-
lowed by sorting on a FACSAria (BD) on the CD8+ and CD45.2 cells. To avoid
complications in the VITAL assay, we did not directly stain BA-CTLs with
CD45.1. RMA control cells were labeled with a low dose (0.2 mM) of CellTrace
Violet (CTV; Invitrogen), and RMA-Rae1e-expressing target cells were labeled
with a higher dose of CTV (5 mM). The cells were mixed at a 1:1 ratio and incu-
bated with OT-I BA-CTLs for 6 hr in vitro at an effector-to-target (E:T) ratio of
6:1. The CTV low-to-high ratio of the remaining live cells was determined by
fluorescence-activated cell sorting (FACS) analysis. Dead cells were excluded
by propidium iodide staining.
Ab Blocking and Depletion Experiments
NK1.1 (PK136) and/or NKG2D (HMG2D) Ab was injected i.p. (100–200 mg)
2 days before and after infection with LM. NK cell depletion was confirmed
by FACS analysis using an NKp46 Ab.
Flow Cytometry
Mice were sacrificed at the time points indicated. For intracellular staining,
cells were prepared with the Cytofix/Cytoperm kit (BD). IFNg assays were per-
formed in the presence of brefeldin A (BD) and incubated with or without
100 nM SIINFEKL peptide for 4–5 hr in complete RP10. Cells were stained
with the LIVE/DEAD cell stain kit (Invitrogen) prior to FACS analysis. Overall
Rae-1 expression was measured using a pan-Rae-1 Ab (R&D Systems). All
other antibodies were purchased from eBioscience, BioLegend, Invitrogen
(granzyme B), and BD PharMingen. Cells were analyzed using an LSRII flow
cytometer (BD) and analyzed using FlowJo (TreeStar) software.
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